GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Syneron Medical Ltd (NAS:ELOS) » Definitions » Beta

Syneron Medical (Syneron Medical) Beta : N/A (As of May. 12, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Syneron Medical Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-12), Syneron Medical's Beta is Not available.


Syneron Medical Beta Historical Data

The historical data trend for Syneron Medical's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneron Medical Beta Chart

Syneron Medical Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.19 1.47 1.07 1.43 0.89

Syneron Medical Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 1.34 1.11 0.89 1.02

Competitive Comparison of Syneron Medical's Beta

For the Medical Devices subindustry, Syneron Medical's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syneron Medical's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Syneron Medical's Beta distribution charts can be found below:

* The bar in red indicates where Syneron Medical's Beta falls into.



Syneron Medical Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Syneron Medical  (NAS:ELOS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Syneron Medical Beta Related Terms

Thank you for viewing the detailed overview of Syneron Medical's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneron Medical (Syneron Medical) Business Description

Traded in Other Exchanges
N/A
Address
Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments. The Company's products, which it sells mainly to physicians and other practitioners, target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis and topical skin brightening products.
Executives
North Tide Capital, Llc 10 percent owner 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
Laughlin Conan director, 10 percent owner C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
North Tide Capital Master, Lp 10 percent owner C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116

Syneron Medical (Syneron Medical) Headlines